Encompass Health Corporation

Encompass Health Corporation's next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, Encompass Health Corporation has 98.80M shares outstanding.

As of June 30, 2026, Encompass Health Corporation maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.12, indicating elevated leverage, while an interest coverage ratio of 11.63 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Encompass Health Corporation posted a return on equity (ROE) of 25.46, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 14.67 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.72, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.42, useful for judging operating efficiency across full business cycles. The company generates approximately 2.60M in revenue per employee across its workforce of 41,725.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Encompass Health Corporation recorded 3.67B in income tax expense. That works out to an effective tax rate of 20.46, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 17.96B, leaving 10.85B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Encompass Health Corporation generated 108.43B in revenue and converted that into 10.85B in net income, yielding earnings per share of 141.12. EBITDA reached 25.51B, while operating income came in at 19.52B.

As of June 30, 2026, Encompass Health Corporation holds 1.88B in cash and equivalents against 49.66B in total debt, resulting in a net debt position of 44.14B. Total book value stands at 45.39B, with working capital of 2.93B providing operational flexibility.

Encompass Health Corporation produced 21.18B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -13.96B in capital expenditures, free cash flow totaled 7.22B - equivalent to 72.46 per share.

Over the twelve months ended June 30, 2026, Encompass Health Corporation posted a gross margin of 95.82, reflecting its pricing power and cost economics. The operating margin of 18.00 and net profit margin of 10.01 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Encompass Health Corporation paid dividends of 13.18 per share. The dividend payout ratio of 7.30 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Encompass Health Corporation's most recent stock split took place on October 26, 2006 with a 5:1 split ratio.